Venkatramani Srinivasan sold $107K of BLND

Venkatramani Srinivasan (Head of Product Tech & Cust Op) sold 74,705 shares of Blend Labs, Inc. (BLND) at $1.43 ($0.11M total) on 2026-09-11 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Venkatramani Srinivasan
Published Sep 15, 2026, 9:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 9:04 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BLND
Bearish
medium confidence
Mentioned
$BLND
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BLNDBearishLow
01

Why it matters

The disclosed sale is modest in dollar terms but provides a fresh data point for traders monitoring BLND.

02

Market read

New insider sale adds to the flow of information on BLND, offering a slight bearish cue.

03

What to watch

Potential upcoming product milestones could offset the negative signal from the insider sale.

Relevance 3/10Novelty 4/10Timing: filed today

Background

SEC Form 4 filing discloses insider transactions; such filings are primary sources for insider activity.

Company-level read

Ticker impact

$BLNDBearishMedium confidence
Context

Head of Product Tech & Cust Op sold 74,705 shares for $106,828 via a 10b5‑1 plan on 2026‑09‑11.

Expected impact

Slight downward move in short term.

Evidence & confidence

Insider sale of ~0.3% of holdings signals possible lack of confidence; amount is modest but may influence sentiment.

Market effects

None

None

None

Counterpoint

The sale may be routine under a pre‑arranged plan and not reflect underlying fundamentals.

Key entities

  • Blend Labs, Inc.

    US‑listed software company (NASDAQ: BLND).

  • Venkatramani Srinivasan

    Head of Product Tech & Cust Op at Blend Labs.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BLNDMed

Blend Announces Third Quarter 2026 Financial Results

Blend Labs, Inc. (BLND) filed an SEC Form 8-K — Results of Operations and Financial Condition. Blend Announces Third Quarter 2026 Financial Results November 5, 2026 SAN FRANCISCO -- Blend Labs, Inc. (NYSE: BLND), a leading digital banking platform, today announced its third quarter 2026 financial results. “We had our best sales quarter in more than three years,” said Nima

$BLNDMed

Blend Announces Second Quarter 2026 Financial Results

Blend Labs, Inc. (BLND) filed an SEC Form 8-K — Results of Operations and Financial Condition. Blend Announces Second Quarter 2026 Financial Results August 6, 2026 SAN FRANCISCO -- Blend Labs, Inc. (NYSE: BLND), a leading origination platform for digital banking solutions, today announced its second quarter 2026 financial results. "We delivered Q2 with revenue near the hig

$BLNDMed

British Land reports strong Q1 leasing momentum By Investing.com

British Land reported Q1 FY2027 leasing of 567,000 sq ft, completed at 4.8% above estimated rental value and 8.7% above prior passing rents. An extra 1.1m sq ft is under offer. Near-full occupancy was noted for retail parks and London Urban Logistics. Disposals totaled £83m at 3.2% net initial yield. FY2027 underlying EPS guidance of at least 30.5p was kept.